MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,06,07,08,company represent report with the FDA on 2015-04-13 for ORTHOBLAST-II PASTE 02-2100-010 manufactured by Isotis Orthobiologics, Inc.
[5650110]
It was reported that following an interbody fusion surgery osteolysis was found. The product was removed when osteolysis was found. It was reported the current opinion is the problem is not because of the orthoblast product. The pt was elderly, over 70 years old, and had combined orthopedic surgery (posterolateral fusion, interbody fusion with bone substitute). Add'l info has been requested.
Patient Sequence No: 1, Text Type: D, B5
[13130672]
To date, the device involved in the reported incident has not been received for eval. An investigation has been initiated based upon the reported info.
Patient Sequence No: 1, Text Type: N, H10
[62390608]
Integra has completed their internal investigation on 07/13/2015. Methods, review of device history records, review of complaint history - results: no product samples, nor support documentation, were retuned to the manufacturer. No product was retuned to the manufacturer. Additionally, the lot number of the product was not confirmed. The orthoblast 11 paste product is suspected to be manufactured under lot number 141899. The complete device history record was reviewed and no anomalies were noted. The product was manufactured and released in accordance with product specifications. The demineralization record for the demineralized bone used in lot number 141899 was reviewed and no anomalies were noted. The applicable donor files were reviewed and no anomalies were noted. All donors are prescreened by a medical director at our tissue bank for serology and microbial cultures. A retain sample was reviewed and no anomalies were detected. The complaint database was reviewed for the last two years and such review indicated there were no other related complaints for this product. Conclusion: no product was returned to the manufacturer. Additionally, the lot number of the product was not confirmed. The orthoblast il paste product is "suspected" to be manufactured under lot number 141899. The complete device history record was reviewed and no anomalies were noted. The product was not used as intended osteolysis cannot be determined in such a short time period in accordance with the directions for use which states "sites grafted with orthoblast 11 should be allowed to heal approximately 6 months prior to implant placement. " resultantly, no root cause could be determined.
Patient Sequence No: 1, Text Type: N, H10
Report Number | 2090010-2015-00006 |
MDR Report Key | 4691853 |
Report Source | 01,06,07,08,COMPANY REPRESENT |
Date Received | 2015-04-13 |
Date of Report | 2015-03-16 |
Date Mfgr Received | 2015-03-16 |
Date Added to Maude | 2015-04-16 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MARIA LEONARD |
Manufacturer Street | 311 ENTERPRISE DR |
Manufacturer City | PLAINSBORO NJ 08536 |
Manufacturer Country | US |
Manufacturer Postal | 08536 |
Manufacturer Phone | 6099362341 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | ORTHOBLAST-II PASTE |
Generic Name | ORTHOBLAST |
Product Code | MBP |
Date Received | 2015-04-13 |
Catalog Number | 02-2100-010 |
Lot Number | 141899 (SUSPECTED LOT) |
Operator | HEALTH PROFESSIONAL |
Device Availability | N |
Device Age | DA |
Device Eval'ed by Mfgr | R |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | ISOTIS ORTHOBIOLOGICS, INC |
Manufacturer Address | IRVINE CA 92618 US 92618 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Required No Informationntervention | 2015-04-13 |